Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population.

J. Skrickova; L. Babickova; M. Tomiskova; B. Kadlec

doi:10.1200/jco.2010.28.15_suppl.e18061

Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18061 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18061-e18061

Author(s):

J. Skrickova ◽

L. Babickova ◽

M. Tomiskova ◽

B. Kadlec

Keyword(s):

Lung Cancer ◽

Prospective Study ◽

Line Treatment ◽

First Line ◽

Oral Vinorelbine ◽

A Prospective Study ◽

Nsclc Patients ◽

First Line Treatment

Download Full-text

Full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonrandomized population of 259 patients

Lung Cancer ◽

10.1016/j.lungcan.2012.05.073 ◽

2012 ◽

Vol 77 ◽

pp. S37-S38

Author(s):

Jana Skřičková ◽

Bohdan Kadlec ◽

Ondřej Venclíček ◽

Tereza Janásková ◽

Jiří Bartoš ◽

...

Keyword(s):

Lung Cancer ◽

Prospective Study ◽

Line Treatment ◽

First Line ◽

Oral Vinorelbine ◽

A Prospective Study ◽

Nsclc Patients ◽

First Line Treatment

Download Full-text

Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary

Clinical & Translational Oncology ◽

10.1007/s12094-012-0989-6 ◽

2013 ◽

Vol 15 (8) ◽

pp. 659-664 ◽

Cited By ~ 3

Author(s):

M. Provencio ◽

A. Sánchez ◽

A. Artal ◽

J. M. Sánchez Torres ◽

J. de Castro ◽

...

Keyword(s):

Lung Cancer ◽

Prospective Study ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

A Prospective Study ◽

First Line Treatment

Download Full-text

Erratum to: Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary

Clinical & Translational Oncology ◽

10.1007/s12094-013-1050-0 ◽

2013 ◽

Vol 15 (8) ◽

pp. 670-670

Author(s):

M. Provencio ◽

A. Sánchez ◽

A. Artal ◽

J. M. Sánchez Torres ◽

R. García Gómez ◽

...

Keyword(s):

Lung Cancer ◽

Prospective Study ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

A Prospective Study ◽

First Line Treatment

Download Full-text

Full Oral Vinorelbine (NVBO) on D1 and D8 With Carboplatin (CBDCA) as First Line Treatment in Advanced Non-small Cell Lung Cancer (NSCLC) Patients: Preliminary Results of a Prospective Sudy in Nonrandomized Population

CHEST Journal ◽

10.1378/chest.1103753 ◽

2011 ◽

Vol 140 (4) ◽

pp. 956A

Author(s):

Jana Skrickova ◽

Marcela Tomiskova ◽

Lenka Babickova ◽

Tereza Janaskova ◽

Vitezslav Kolek ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Nsclc Patients ◽

First Line Treatment

Download Full-text

1016 Oral vinorelbine (NVBo) in Asian Advanced Breast Cancer (ABC) and Non Small Cell Lung Cancer (NSCLC) patients (pts): Pharmacokinetics (PK) coupled with efficacy and safety as first line treatment - A Chinese experience

European Journal of Cancer ◽

10.1016/s0959-8049(16)30442-7 ◽

2015 ◽

Vol 51 ◽

pp. S150

Author(s):

L. Zhang ◽

S. Zhimin ◽

S. Yongqian ◽

J. Zefei ◽

W. Jie ◽

...

Keyword(s):

Breast Cancer ◽

Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Nsclc Patients ◽

First Line Treatment

Download Full-text

PCN43 THE ASSOCIATION OF TUMOR HISTOLOGY WITH FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES AMONG

Value in Health ◽

10.1016/s1098-3015(10)70221-7 ◽

2008 ◽

Vol 11 (3) ◽

pp. A67

Author(s):

K Lang ◽

M Marciniak ◽

D Faries ◽

KM Clements ◽

J Nyambose ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Medical Care Costs ◽

Nsclc Patients ◽

Care Costs ◽

First Line Treatment

Download Full-text

Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2785-9 ◽

2015 ◽

Vol 76 (2) ◽

pp. 235-242 ◽

Cited By ~ 3

Author(s):

Fadi S. Farhat ◽

Marwan G. Ghosn ◽

Joseph G. Kattan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

First Line Treatment

Download Full-text

P2-159: Phase III randomized study of oral vinorelbine (oV) and gemcitabine (G) (oVG) versus docetaxel (D) and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): A preliminary report

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283817.86250.51 ◽

2007 ◽

Vol 2 (8) ◽

pp. S632 ◽

Cited By ~ 1

Author(s):

S Agelaki ◽

N Androulakis ◽

A Agelidou ◽

M Agelidou ◽

A Kotsakis ◽

...

Keyword(s):

Lung Cancer ◽

Preliminary Report ◽

Randomized Study ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

First Line Treatment

Download Full-text

A prospective study to assess the efficacy and safety of oral propranolol as first-line treatment for infantile superficial hemangioma

Korean Journal of Pediatrics ◽

10.3345/kjp.2015.58.12.484 ◽

2015 ◽

Vol 58 (12) ◽

pp. 484 ◽

Cited By ~ 10

Author(s):

Yeong Ju Yun ◽

Yun Hee Gyon ◽

Sohyoung Yang ◽

Youn Kyung Lee ◽

Joohyun Park ◽

...

Keyword(s):

Prospective Study ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

A Prospective Study ◽

Oral Propranolol ◽

First Line Treatment

Download Full-text

Evaluation of epidermal growth factor receptor (EGFR) as a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy as first-line treatment

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7024 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7024-7024 ◽

Cited By ~ 2

Author(s):

M. Janas ◽

L. R. Bailey ◽

K. Schmidt ◽

N. Bindslev ◽

M. Wolf ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

Epidermal Growth ◽

Nsclc Patients ◽

First Line Treatment

Download Full-text